Chargement en cours...

The journey to understanding incretin systems: Theory, practice and more theory

Accumulating clinical data on incretin‐based dipeptidyl peptidase‐4 inhibitors and glucagon‐like peptide‐1 receptor agonists in the past decade have clearly confirmed their safety and efficacy as antidiabetes drugs. However, the journey to understand the incretin system and its role in health and di...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Diabetes Investig
Auteurs principaux: Yabe, Daisuke, Kuwata, Hitoshi, Seino, Yutaka
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2019
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6717807/
https://ncbi.nlm.nih.gov/pubmed/31361402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13123
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!